Lipin 2 (LPIN2) (C-Term) Peptide
LPIN2
Reactivity: Human
Host: Synthetic
BP, WB
Catalog No. ABIN979545
Quick Overview for Lipin 2 (LPIN2) (C-Term) Peptide (ABIN979545)
Target
Lipin 2 (LPIN2)
Origin
Human
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- C-Term
-
Sequence
- ELIQERTKGN KSSYHRLSEL VEHVFPLLSK EQNSAFPCPE FSSFCYWRDP
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-LPIN2 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- Lipin 2 (LPIN2)
-
Background
-
Mouse studies suggest that this gene functions during normal adipose tissue development and may play a role in human triglyceride metabolism. This gene represents a candidate gene for human lipodystrophy, characterized by loss of body fat, fatty liver, hypertriglyceridemia, and insulin resistance.
Alias Symbols: KIAA0249
Protein Size: 896 -
Molecular Weight
- 99 kDa
-
Gene ID
- 9663
-
NCBI Accession
- NM_014646, NP_055461
-
UniProt
- Q92539
Target
-
You are here:
